Delayed-type hypersensitivity reaction to ethambutol and isoniazid

Autor: Bakkum, RSLA (R. S L A), Waard-van der Spek, FB, Thio, Bing

Publikováno v: Contact Dermatitis, 46, 359-359. Wiley-Blackwell Publishing Ltd

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::23c6bab738724ae0a6b91c5cb12730c5
https://pure.eur.nl/en/publications/8885e81a-fff1-49aa-871f-879c26b078aa

Granulomateuze en systemische reactie na lokale injectie van collageen

Autor: Bakkum, RSLA (R. S L A), van Hagen, P.M., Thio, Bing

Publikováno v: Nederlands Tijdschrift voor Dermatologie & Venereologie, 12, 36-37. DCHG Partners in Mediscne Communicatie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::434d87a45050403f85bc8da37a43d5cb
https://pure.eur.nl/en/publications/ee4f59d8-ac40-4ba9-9dea-35cb1c9f1f8c

Xanthomen bij primaire biliaire cirrhose, remissie na levertransplantatie

Autor: Bakkum, RSLA (R. S L A), Honig, E, Heide, R

Publikováno v: Nederlands Tijdschrift voor Dermatologie & Venereologie, 12, 58-59. DCHG Partners in Mediscne Communicatie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::65ef6ca6181dcb8ef01f01cdcd9febc6
https://pure.eur.nl/en/publications/0ed3ae6c-e269-44bb-8910-34dd9bf104ca

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care.

Autor: van Egmond S; Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Vliet ED; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Wakkee M; Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hollestein LM; Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., Pouwels XGLV; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Koffijberg H; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Misirli Y; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., Bakkum RSLA; Department of Dermatology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands., Bastiaens MT; Department of Dermatology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Kukutsch NA; Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands., Oosting AJ; Department of Dermatology, Spaarne Ziekenhuis, Hoofddorp, The Netherlands., Plasmeijer EI; Department of Dermatology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van Rengen A; Department of Dermatology, Mohs Klinieken, Dordrecht, The Netherlands., de Roos KP; Department of Dermatology, DermaPark, Uden, The Netherlands., Nijsten TEC; Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Vries E; Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogota, Colombia., de Bekker-Grob EW; Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, The Netherlands.

Publikováno v: PloS one [PLoS One] 2022 Jan 24; Vol. 17 (1), pp. e0260978. Date of Electronic Publication: 2022 Jan 24 (Print Publication: 2022).